What does R. Stael Reumatologie do?

R. Stael Reumatologie is a specialist medical practice in Wortegem-Petegem. Private Limited, started on 25 May 2018, 1 establishment.

What is the address of R. Stael Reumatologie?

The registered office of R. Stael Reumatologie is located at Bergstraat (P.) 1, 9790 Wortegem-Petegem.

Is R. Stael Reumatologie still active?

Yes. According to the CBE (17 September 2026) R. Stael Reumatologie is active, legal situation “Normale toestand”, started on 25 May 2018.

Is R. Stael Reumatologie registered on Peppol?

Yes, R. Stael Reumatologie is registered on the Peppol network with ID 0208:0696778417.

What is the enterprise number of R. Stael Reumatologie?

The enterprise number of R. Stael Reumatologie is BE0696778417.

When was R. Stael Reumatologie founded?

R. Stael Reumatologie was founded on 25 May 2018.

Who are the directors of R. Stael Reumatologie?

According to the 2025 annual accounts, the directors of R. Stael Reumatologie are: Rebecca Stael.

Is R. Stael Reumatologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 May 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did R. Stael Reumatologie make in 2025?

R. Stael Reumatologie posted a profit after taxes of € 147,906 in financial year 2025.

What is the revenue of R. Stael Reumatologie?

As a small company, R. Stael Reumatologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 209,401.

R. Stael Reumatologie (Private Limited)

Dossier R. Stael Reumatologie, printed on 17 September 2026 from databakkes.be/en/0696778417/r-stael-reumatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 56 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

R. Stael Reumatologie from Wortegem-Petegem, company number BE0696778417, closed financial year 2025 with a result of € 147,906 after tax. For that financial year R. Stael Reumatologie recorded a gross margin of € 209,401 and equity of € 24,506. Compared with financial year 2024, the result moved from € 141,912 to € 147,906. Profitable, and profit is growing. The buffer shrank hard: equity is 93 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Shrank hard

€ 24,506

▼ 93% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 147,906

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 237,538

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 477,862 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 20,417

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,623

▲ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,038

▲ 160% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 129,604 Gross margin 2022: € 129,604 First fiscal year in the series	€ 172,711 Gross margin 2023: € 172,711 ▲ 33% vs 2022 (€ 129,604) Favourable step	€ 202,810 Gross margin 2024: € 202,810 ▲ 17% vs 2023 (€ 172,711) Favourable step	€ 209,401 Gross margin 2025: € 209,401 ▲ 3% vs 2024 (€ 202,810) Favourable step	▲ 3%
Profit after taxes	€ 89,482 Profit after taxes 2022: € 89,482 First fiscal year in the series	€ 119,179 Profit after taxes 2023: € 119,179 ▲ 33% vs 2022 (€ 89,482) Favourable step	€ 141,912 Profit after taxes 2024: € 141,912 ▲ 19% vs 2023 (€ 119,179) Favourable step	€ 147,906 Profit after taxes 2025: € 147,906 ▲ 4% vs 2024 (€ 141,912) Favourable step	▲ 4%
Equity	€ 153,372 Equity 2022: € 153,372 First fiscal year in the series	€ 242,551 Equity 2023: € 242,551 ▲ 58% vs 2022 (€ 153,372) Favourable step	€ 354,462 Equity 2024: € 354,462 ▲ 46% vs 2023 (€ 242,551) Favourable step	€ 24,506 Equity 2025: € 24,506 ▼ 93% vs 2024 (€ 354,462) Unfavourable step	▼ 93%
Total debts	€ 51,693 Total debts 2022: € 51,693 First fiscal year in the series	€ 53,884 Total debts 2023: € 53,884 ▲ 4% vs 2022 (€ 51,693) Unfavourable step	€ 53,320 Total debts 2024: € 53,320 ▼ 1% vs 2023 (€ 53,884) Favourable step	€ 423,416 Total debts 2025: € 423,416 ▲ € 370,095 vs 2024 (€ 53,320) Unfavourable step	▲ € 370,095
Cash	€ 164,754 Cash 2022: € 164,754 First fiscal year in the series	€ 235,548 Cash 2023: € 235,548 ▲ 43% vs 2022 (€ 164,754) Favourable step	€ 360,412 Cash 2024: € 360,412 ▲ 53% vs 2023 (€ 235,548) Favourable step	€ 237,538 Cash 2025: € 237,538 ▼ 34% vs 2024 (€ 360,412) Unfavourable step	▼ 34%
Retained profit	€ 134,772 Retained profit 2022: € 134,772 First fiscal year in the series	€ 223,951 Retained profit 2023: € 223,951 ▲ 66% vs 2022 (€ 134,772) Favourable step	€ 335,862 Retained profit 2024: € 335,862 ▲ 50% vs 2023 (€ 223,951) Favourable step	€ 5,906 Retained profit 2025: € 5,906 ▼ 98% vs 2024 (€ 335,862) Unfavourable step	▼ 98%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 Unchanged (€ 30,000) Unchanged	€ 30,000 Dividend 2024: € 30,000 Unchanged (€ 30,000) Unchanged	€ 477,862 Dividend 2025: € 477,862 ▲ € 447,862 vs 2024 (€ 30,000) Unchanged	▲ € 447,862
Balance sheet total	€ 205,065 Balance sheet total 2022: € 205,065 First fiscal year in the series	€ 296,434 Balance sheet total 2023: € 296,434 ▲ 45% vs 2022 (€ 205,065) Unchanged	€ 407,782 Balance sheet total 2024: € 407,782 ▲ 38% vs 2023 (€ 296,434) Unchanged	€ 447,922 Balance sheet total 2025: € 447,922 ▲ 10% vs 2024 (€ 407,782) Unchanged	▲ 10%

Key figures of R. Stael Reumatologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to R. Stael Reumatologie?

What happened at R. Stael Reumatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 147,906 (▲ 4% vs 2024). Source: NBB ↗
May 25, 2018 New establishment in Wortegem-Petegem. KBO
2018 Rebecca Stael became a director. NBB
May 25, 2018 Start of the company according to the CBE. KBO

In short

From € 89,482 profit in 2022 to € 147,906 profit in 2025.

Paid € 144,915 in corporate taxes since 2022.

Best year ever: 2025, with € 147,906 profit.

Paid out € 567,862 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at R. Stael Reumatologie? We notify you, reason included.

Follow R. Stael Reumatologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Rebecca Stael

R. Stael Reumatologie

Behind R. Stael Reumatologie is Rebecca Stael.

See the full network in the app

Directors

According to the 2025 annual accounts

Rebecca Stael

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Bergstraat (P.) 1

9790 Wortegem-Petegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

GOBELIJN

€ 29,963 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0696.778.417
VAT number: BE 0696.778.417
Registered office: Bergstraat (P.) 1, 9790 Wortegem-Petegem
Names & denominations: R. Stael Reumatologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 May 2018
Peppol: Active · Active since 2 Dec 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗